Metodip, Metoprolol 12.5 mg Extended Release, Metoprolol, Metodip-12.5, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
Metodip, Metoprolol 25 mg Extended Release, Metoprolol, Metodip-25 ER, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, metodip-50 er, metodip-a
Metodip, Metoprolol 12.5 mg Extended Release, Metoprolol, Metodip-12.5, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
Metodip, Metoprolol 25 mg Extended Release, Metoprolol, Metodip-25 ER, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, metodip-50 er, metodip-a

METODIP

TAB METODIP-12.5 ER (Metoprolol 12.5 mg Extended Release) BILSTER 10 X 10
TAB METODIP-25 ER (Metoprolol 25 mg Extended Release) BILSTER 10 X 10
TAB METODIP-50 ER (Metoprolol 50 mg Extended Release) BILSTER 10 X 10
TAB METODIP-A (Metoprolol 50 mg + Amlodipine 5 mg ) BILSTER 10 X 10
Category: Tag:
Send Enquiry

Introduction:

METODIP is a clinically effective line of Metoprolol-based extended-release tablets, designed for long-term management of hypertension, angina pectoris, and other cardiovascular conditions. It also includes a combination formulation with Amlodipine, enhancing efficacy for patients requiring dual antihypertensive therapy. The ER (Extended Release) formulations offer once-daily dosing, ensuring steady plasma concentration and improved patient adherence.

Available in blister packaging (10 x 10 tablets) for dosage accuracy and shelf-life preservation.

Product Variants & Composition:

METODIP-12.5 ER
Composition: Metoprolol 12.5 mg (Extended Release)
Packaging: Blister | 10 x 10 Tablets

METODIP-25 ER
Composition: Metoprolol 25 mg (Extended Release)
Packaging: Blister | 10 x 10 Tablets

METODIP-50 ER
Composition: Metoprolol 50 mg (Extended Release)
Packaging: Blister | 10 x 10 Tablets

METODIP-A
Composition: Metoprolol 50 mg + Amlodipine 5 mg
Packaging: Blister | 10 x 10 Tablets

Key Benefits:

  • Metoprolol ER: Provides sustained β1-selective adrenergic blockade with 24-hour control of blood pressure and heart rate.

  • Reduces myocardial oxygen demand, controlling angina and improving exercise tolerance.

  • Helps in secondary prevention of myocardial infarction and managing heart failure symptoms.

  • Combination variant (METODIP-A) offers synergistic BP control via β-blockade and calcium channel blockade.

  • Once-daily dosing improves compliance, especially in chronic cardiac patients.

Indications:

  • Essential hypertension

  • Stable angina pectoris

  • Heart failure (with reduced ejection fraction)

  • Post-myocardial infarction secondary prevention

  • Palpitations and arrhythmias (especially supraventricular)

  • Dual therapy with METODIP-A in patients unresponsive to monotherapy

Dosage & Administration:

  • Start with the lowest effective dose (e.g., 12.5–25 mg daily), titrate based on clinical response.

  • METODIP-A is typically given once daily with or without food.

  • Regular monitoring of blood pressure, heart rate, and renal function is recommended.

Precautions & Warnings:

  • Avoid abrupt withdrawal; taper gradually to prevent rebound hypertension or angina.

  • Use caution in asthma/COPD, bradycardia, or heart block.

  • Not advised in acute heart failure or cardiogenic shock.

  • Monitor for signs of hypotension or dizziness, especially in elderly patients.

Possible Side Effects:

  • Fatigue, dizziness, bradycardia

  • Cold extremities, insomnia

  • Rare: AV block, hypotension, bronchospasm (in predisposed individuals)

  • Peripheral edema (with Amlodipine combination)

Conclusion:

The METODIP range offers a reliable and clinically validated solution for cardiovascular management. From monotherapy to fixed-dose combinations, METODIP delivers enhanced cardiovascular protection with sustained action and minimal side effects.

Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.

For more such product information and similar product category Cardiac Miscellaneous Diabetic

You can also contact us  https://diabetes-cardiac.com/contact-us/

Related products